These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 27091647
1. Neutrophilic superoxide production can assess pharmacological and pharmacogenetic β-adrenoreceptor effects. Reinartz MT, Wetzke M, Happle C, Kälble S, Scherer R, Kabesch M, Seifert R. Allergy; 2016 Aug; 71(8):1223-7. PubMed ID: 27091647 [Abstract] [Full Text] [Related]
2. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M. Lancet; 2007 Dec 22; 370(9605):2118-25. PubMed ID: 18156033 [Abstract] [Full Text] [Related]
3. The β2-adrenoreceptor gene promoter polymorphisms may modulate β2-agonist- and glucocorticoid-induced IgE synthesis. Chalubinski M, Grzegorczyk J, Grzelak A, Jarzebska M, Kowalski ML. Allergol Immunopathol (Madr); 2014 Dec 22; 42(6):586-93. PubMed ID: 24182991 [Abstract] [Full Text] [Related]
4. Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma. Taylor DR, Epton MJ, Kennedy MA, Smith AD, Iles S, Miller AL, Littlejohn MD, Cowan JO, Hewitt T, Swanney MP, Brassett KP, Herbison GP. Am J Respir Crit Care Med; 2005 Sep 15; 172(6):700-3. PubMed ID: 15976384 [Abstract] [Full Text] [Related]
5. Polymorphism of the ADRB2 gene and response to inhaled beta- agonists in children with asthma: a meta-analysis. Finkelstein Y, Bournissen FG, Hutson JR, Shannon M. J Asthma; 2009 Nov 15; 46(9):900-5. PubMed ID: 19905915 [Abstract] [Full Text] [Related]
6. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. Ortega VE, Meyers DA. J Allergy Clin Immunol; 2014 Jan 15; 133(1):16-26. PubMed ID: 24369795 [Abstract] [Full Text] [Related]
7. Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations. Carroll CL, Stoltz P, Schramm CM, Zucker AR. Chest; 2009 May 15; 135(5):1186-1192. PubMed ID: 19029431 [Abstract] [Full Text] [Related]
9. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms. Tellería JJ, Blanco-Quirós A, Muntión S, Antonio Garrote J, Arranz E, Armentia A, Díez I, Castro J. Respir Med; 2006 Jun 15; 100(6):1072-8. PubMed ID: 16263254 [Abstract] [Full Text] [Related]
10. Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics. Bandaru S, Akka J, Marri VK, Alvala M, Ponnala D, Mundluru HP. Inflammation; 2015 Dec 15; 38(6):2146-55. PubMed ID: 26071206 [Abstract] [Full Text] [Related]
11. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*. Kukreti R, Bhatnagar P, B-Rao C, Gupta S, Madan B, Das C, Guleria R, Athavale AU, Brahmachari SK, Ghosh B. Pharmacogenomics; 2005 Jun 15; 6(4):399-410. PubMed ID: 16004558 [Abstract] [Full Text] [Related]
12. Single nucleotide polymorphisms of ADRB2 gene and their association with susceptibility for Plasmodium falciparum malaria and asthma in an Indian population. Saadi AV, Gupta H, Angural A, Dhanya SK, Mony S, Oberoi D, D'Souza SC, Sahoo RC, Hande MH, Gopinath PM, Satyamoorthy K. Infect Genet Evol; 2013 Dec 15; 20():140-7. PubMed ID: 24012958 [Abstract] [Full Text] [Related]
13. The effect of polymorphism of the beta-2 adrenergic receptor on the response to beta-2 agonist in bronchial asthma patients. Syamsu, Yusuf I, Budu, Patellongi I. Acta Med Indones; 2007 Dec 15; 39(1):8-12. PubMed ID: 17297203 [Abstract] [Full Text] [Related]
14. ADRB2 Gly16Arg polymorphism, asthma control and lung function decline. Rebordosa C, Kogevinas M, Guerra S, Castro-Giner F, Jarvis D, Cazzoletti L, Pin I, Siroux V, Wjst M, Antò JM, de Marco R, Estivill X, Corsico AG, Nielsen R, Janson C. Eur Respir J; 2011 Nov 15; 38(5):1029-35. PubMed ID: 21436355 [Abstract] [Full Text] [Related]
15. Pharmacogenetics of β2-agonists. Hizawa N. Allergol Int; 2011 Sep 15; 60(3):239-46. PubMed ID: 21681016 [Abstract] [Full Text] [Related]
16. Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma. Hancox RJ, Sears MR, Taylor DR. Eur Respir J; 1998 Mar 15; 11(3):589-93. PubMed ID: 9596107 [Abstract] [Full Text] [Related]
17. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. Bleecker ER, Yancey SW, Baitinger LA, Edwards LD, Klotsman M, Anderson WH, Dorinsky PM. J Allergy Clin Immunol; 2006 Oct 15; 118(4):809-16. PubMed ID: 17030231 [Abstract] [Full Text] [Related]
18. Polymorphisms of the β2-adrenergic receptor correlated to nocturnal asthma and the response of terbutaline nebulizer. Lee MY, Cheng SN, Chen SJ, Huang HL, Wang CC, Fan HC. Pediatr Neonatol; 2011 Feb 15; 52(1):18-23. PubMed ID: 21385652 [Abstract] [Full Text] [Related]
19. Pharmacogenetics of beta2-agonist drugs in asthma. Taylor DR. Clin Rev Allergy Immunol; 2006 Feb 15; 31(2-3):247-58. PubMed ID: 17085797 [Abstract] [Full Text] [Related]
20. β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response. Isaza C, Sepúlveda-Arias JC, Agudelo BI, Arciniegas W, Henao J, Porras GL, Beltrán L. Pediatr Pulmonol; 2012 Sep 15; 47(9):848-55. PubMed ID: 22328447 [Abstract] [Full Text] [Related] Page: [Next] [New Search]